William Blair analyst Jonathan Ho downgrades Fastly (NYSE:FSLY) from Outperform to Market Perform.
Morgan Stanley Maintains Equal-Weight on DexCom, Lowers Price Target to $570
Morgan Stanley maintains DexCom (NASDAQ:DXCM) with a Equal-Weight and lowers the price target from $576 to $570.